Search Results for "Ncs Diagnostics Inc Canada"

15:49 EST 21st December 2014 | BioPortfolio

Original Source: Somagen Diagnostics

Somagen was founded as Immucor Canada Inc. in 1988 by Thomas E Brown and Roland Person. In its early days the business focused on supplying the Canadian Blood Bank market. By 1995 the company had begun expanding into other niche laboratory markets and then acquired NCS Diagnostics in a significant step toward expansion. Kevin Blackburn, who would become the company's third partner, joined the business in 1996. Expansion into new markets within the clinical lab continued over the next several years. Immucor ...

Matching Channels

Roche

Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...

Hepatitis B Immune Globulin Cangene

HepaGam B® [Hepatitis B Immune Globulin (Human) Injection] contains purified antibodies specific for the hepatitis B surface antigen (HBsAg). * It is approved in Canada and the United States f...

Alto Marketing - specialist healthcare and life science communications consultancy

Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy.  With extensive experience of worldwide marketing in sectors including (...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Cambridge

In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...

Matching News

Miacom diagnostics receives Health Canada approval for hemoFISH assays

Germany-based Miacom diagnostics has received approval from the Health Canada for its hemoFISH assays, which are designed to help identify and differentiate bacterial pathogens from positive blood cul...

Valeant buys NicOx’ US ophthalmic diagnostics unit

Ophthalmology-focused French biotech firm NicOx says that Canada’s Valeant Pharmaceuticals International has acquired NicOx' US diagnostics subsidiary NicOx Inc.

People on the move (week of September 22)

A bi-weekly roundup of People on the move in Canada’s life science and biotech sectors. Proteocyte Diagnostics announces the appointment of Dr. Mario Thomas to the role of president. With over 25 ye...

International Veterinary Diagnostics (Clinical Chemistry, Hematology Analyzers, Molecular Diagnostics, Immunodiagnostics, Diagnostics Imaging) Market - Forecasts to 2018

Dublin, July 1, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/pfmv2h/veterinary)  has announced the addition of the "International Veterinary Diagnostics ...

AstraZeneca Partners with Roche on Development of a Companion Diagnostic

The topic of companion diagnostics has been of continuing interest for me. I have posted a number of notes about this type of lab test (see, for example: More Details About Roche's Companion Diagnosti...

Roche buys Ariosa Diagnostics

Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into other markets. Californian-based Ariosa is a molecular diagnostics firm t...

WOUNDCHEK™ Laboratories receives market clearance for WOUNDCHEK™ Protease Status in Canada

WOUNDCHEK™ Laboratories announced today that it has received market clearance from Health Canada for WOUNDCHEK™ Protease Status, the world’s first point of care

Bill & Melinda Gates Foundation awards grant to Fio for Ebola diagnostics

Fio has received a grant financed by the Bill & Melinda Gates Foundation to adapt its Fionet solution to connect rapid diagnostics and data in the fight against Ebola. Headquartered in Toronto, Cana...

Matching PubMed Articles

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement